Eevia Health is growing rapidly and has customers in 16 countries and three continents. Turnover was 1.6 M€ in 2019, 2.9 M€ in 2020 and expected to be 7.6 M€ in 2021
Eevia Health employs 22 men and 7 women. It operates a modern manufacturing site in Finland with state-of-the-art green chemistry extraction and purification technologies. The team and a network of external advisors, board members and scientific partners constitute a small life science start-up. Over 4.5 M€ has been invested in equity from 57 shareholders.
kEUR | Q1-21 | Q1-21 | 2020 |
Net sales | 3 234 | 340 | 2 866 |
EBITDA | -94 | -123 | -694 |
Net result of the period | -169 | -154 | -1 023 |
Earnings per share, EUR* | -0.02 | -0.01 | -0.10 |